The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)  

Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC  

Endorsed by the European Stroke Organisation (ESO)

/pdf/2016-esc-guidelines-for-the-management-of-atrial-ba0601yb9m.pdf

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Author(s): Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; de Ferranti, Sarah; Despres, Jean-Pierre; Fullerton, Heather J; Howard, Virginia J; Huffman, Mark D; Judd, Suzanne E; Kissela, Brett M; Lackland, Daniel T; Lichtman, Judith H; Lisabeth, Lynda D; Liu, Simin; Mackey, Rachel H; Matchar, David B; McGuire, Darren K; Mohler, Emile R; Moy, Claudia S; Muntner, Paul; Mussolino, Michael E; Nasir, Khurram; Neumar, Robert W; Nichol, Graham; Palaniappan, Latha; Pandey, Dilip K; Reeves, Mathew J; Rodriguez, Carlos J; Sorlie, Paul D; Stein, Joel; Towfighi, Amytis; Turan, Tanya N; Virani, Salim S; Willey, Joshua Z; Woo, Daniel; Yeh, Robert W; Turner, Melanie B; American Heart Association Statistics Committee and Stroke Statistics Subcommittee

/pdf/heart-disease-and-stroke-statistics-2015-update-a-report-37itwymd10.pdf

Heart disease and stroke statistics-2015 update: A report from the American Heart Association

/pdf/2016-esc-guidelines-for-the-management-of-atrial-36b2cidm1x.pdf

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)

Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It should also read "60 mg"instead of "60 mg (use with caution in 'supranormal' renal function)."In the above-indicated cell, a footnote has also been added to state: "Edoxaban should be used in patients with high creatinine clearance only after a careful evaluation of the individual thromboembolic and bleeding risk."Supplementary Table 9, column 'Edoxaban', row 'Dose reduction in selected patients' (page 16). The cell should read "Edoxaban 60 mg reduced to 30 mg once daily if any of the following: creatinine clearance 15-50 mL/min, body weight <60 kg, concomitant use of dronedarone, erythromycin, ciclosporine or ketokonazole"instead of "Edoxaban 60 mg reduced to 30 mg once daily, and edoxaban 30 mg reduced to 15mg once daily, if any of the following: creatinine clearance of 30-50 mL/min, body weight <60 kg, concomitant us of verapamil or quinidine or dronedarone."

/pdf/2020-esc-guidelines-for-the-diagnosis-and-management-of-38dpic1xu8.pdf

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Renewable energy sources and technologies have potential to provide solutions to the long-standing energy problems being faced by the developing countries. The renewable energy sources like wind energy, solar energy, geothermal energy, ocean energy, biomass energy and fuel cell technology can be used to overcome energy shortage in India. To meet the energy requirement for such a fast growing economy, India will require an assured supply of 3-4 times more energy than the total energy consumed today. The renewable energy is one of the options to meet this requirement. Today, renewable account for about 33% of India's primary energy consumptions. India is increasingly adopting responsible renewable energy techniques and taking positive steps towards carbon emissions, cleaning the air and ensuring a more sustainable future. In India, from the last two and half decades there has been a vigorous pursuit of activities relating to research, development, demonstration, production and application of a variety of renewable energy technologies for use in different sectors. In this paper, efforts have been made to summarize the availability, current status, major achievements and future potentials of renewable energy options in India. This paper also assesses specific policy interventions for overcoming the barriers and enhancing deployment of renewables for the future.

Kapil Kumar

Papers

Renewable energy in India: Current status and future potentials

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.

Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.

Synthetic and medicinal perspective of thiazolidinones: A review

Recent synthetic and medicinal perspectives of tryptanthrin